相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Copper metabolism as a unique vulnerability in cancer
Vinit C. Shanbhag et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
Exosomes mediate intercellular transfer of non-autonomous tolerance to proteasome inhibitors in mixed-lineage leukemia
Maolin Ge et al.
CANCER SCIENCE (2020)
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky et al.
INVESTIGATIONAL NEW DRUGS (2020)
Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy
Anne McMahon et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Stress- and ubiquitylation-dependent phase separation of the proteasome
Sayaka Yasuda et al.
NATURE (2020)
Feasibility of Repurposing Clioquinol for Cancer Therapy
Raheel Khan et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2020)
The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates
Kirby Martinez-Fonts et al.
NATURE COMMUNICATIONS (2020)
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
Fabrizio Fontana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Inhibition of USP14 induces ER stress-mediated autophagy without apoptosis in lung cancer cell line A549
Ali-Asghar Moghadami et al.
CELL STRESS & CHAPERONES (2020)
Copper homeostasis: Emerging target for cancer treatment
Yueqin Li
IUBMB LIFE (2020)
Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway
Da Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy
Ying Peng et al.
MOLECULAR PHARMACEUTICS (2020)
USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer
Arishya Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mitochondria! Regulation of the 26S Proteasome
Thomas Meul et al.
CELL REPORTS (2020)
Evaluation of Antibacterial Activity Expression of the Hinokitiol/Cyclodextrin Complex Against Bacteria
Yutaka Inoue et al.
ACS OMEGA (2020)
Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation
Kirandeep K. Deol et al.
MOLECULAR CELL (2020)
Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency
Yu-Shui Ma et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway
Yueh-Jung Wu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma
Daniela Bruennert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA
Bao-Sai Lu et al.
CANCER CELL INTERNATIONAL (2019)
Novel Copper Complexes That Inhibit the Proteasome and Trigger Apoptosis in Triple-Negative Breast Cancer Cells
Dong-Dong Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
Liling Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A new gold(I) complex-Au(PPh3)PT is a deubiquitinase inhibitor and inhibits tumor growth
Xiaofen Li et al.
EBIOMEDICINE (2019)
Schiff base Cu(II) complexes as inhibitors of proteasome in human cancer cells
K. Konarikova et al.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2019)
Recent advances in metal nanoparticles in cancer therapy
Ankush Sharma et al.
JOURNAL OF DRUG TARGETING (2018)
Development of a copper-clioquinol formulation suitable for intravenous use
Moe Wehbe et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response
L. N. Huiting et al.
LEUKEMIA (2018)
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
Yuning Liao et al.
ONCOGENE (2018)
Emerging Cancer Therapeutic Targets in Protein Homeostasis
Prabhakar Bastola et al.
AAPS JOURNAL (2018)
Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells
Xin Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Wu Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
The deubiquitinase UCHL5/UCH37 positively regulates Hedgehog signaling by deubiquitinating Smoothened
Zizhang Zhou et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2018)
Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase
Xin Chen et al.
BIOMETALS (2018)
Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells
Xin Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
Yuning Liao et al.
CELL DEATH & DISEASE (2017)
A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers
Jianyu Cai et al.
ONCOTARGET (2017)
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
Chong Zhao et al.
ONCOTARGET (2017)
The effects of copper pyrithione, an antifouling agent, on developing zebrafish embryos
Kelly M. Almond et al.
ECOTOXICOLOGY (2016)
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
Chong Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors
Neerav Shukla et al.
CANCER RESEARCH (2016)
A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy
C. Zhao et al.
ONCOGENE (2016)
The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
Xin Wang et al.
SCIENTIFIC REPORTS (2016)
Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study
Anna Maria Santoro et al.
SCIENTIFIC REPORTS (2016)
Targeting copper in cancer therapy: 'Copper That Cancer'
Delphine Denoyer et al.
METALLOMICS (2015)
Deubiquitinase inhibition as a cancer therapeutic strategy
Padraig D'Arcy et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
Ningning Liu et al.
ONCOTARGET (2014)
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
Ningning Liu et al.
SCIENTIFIC REPORTS (2014)
Reversible 26S Proteasome Disassembly upon Mitochondrial Stress
Nurit Livnat-Levanon et al.
CELL REPORTS (2014)
Emerging Mechanistic Insights into AAA Complexes Regulating Proteasomal Degradation
Friedrich Foerster et al.
BIOMOLECULES (2014)
Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes
Jian Zuo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF-kappa B Inhibition and p53 Reactivation in Human Lung Cancer Cells
Binhua Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2013)
A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts
Jinbin Han et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Functions of the 19S complex in proteasomal degradation
Chang-Wei Liu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer
Michael A. Cater et al.
BIOCHEMICAL JOURNAL (2011)
A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells
Fei Wang et al.
CANCER LETTERS (2011)
ATP Binds to Proteasomal ATPases in Pairs with Distinct Functional Effects, Implying an Ordered Reaction Cycle
David M. Smith et al.
CELL (2011)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Molecular study on copper-mediated tumor proteasome inhibition and cell death
Yan Xiao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells
Shumei Zhai et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasome
Sarmad Sahiel Hindo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Ubiquitinated Proteins Activate the Proteasome by Binding to Usp14/Ubp6, which Causes 20S Gate Opening
Andreas Peth et al.
MOLECULAR CELL (2009)
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma
X. Mao et al.
LEUKEMIA (2009)
Copper-Triggered Aggregation of Ubiquitin
Fabio Arnesano et al.
PLOS ONE (2009)
Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells
Haiyuan Zhang et al.
ANTI-CANCER DRUGS (2008)
Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
Boris Cvek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity
Vesna Milacic et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Ubiquitin stability and the Lys63-linked polyubiquitination site are compromised on copper binding
Danilo Milardi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37
Xiao-Bo Qiu et al.
EMBO JOURNAL (2006)
Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells
Shreelekha Adsule et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1
Tingting Yao et al.
NATURE CELL BIOLOGY (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14
M Hu et al.
EMBO JOURNAL (2005)
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis
D Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
KG Daniel et al.
BREAST CANCER RESEARCH (2005)
Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells
KG Daniel et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
DZ Cen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The role of autophagy during the early neonatal starvation period
A Kuma et al.
NATURE (2004)
Uch2/Uch37 is the major deubiquitinating enzyme associated with the 26 S proteasome in fission yeast
M Stone et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Dysfunction of mitochondrial complex I and the proteasome:: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
A cryptic protease couples deubiquitination and degradation by the proteasome
TT Yao et al.
NATURE (2002)
Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression
BY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis
JJ Pink et al.
EXPERIMENTAL CELL RESEARCH (2000)
Pyrithiones as antifoulants: Environmental chemistry and preliminary risk assessment
PA Turley et al.
BIOFOULING (2000)
分享论文
